After publication of the draft Generally Regarded As Safe (GRAS) rule in 1997, the United States (US) Food and Drug Administration (FDA) initiated an Interim Pilot Program encouraging the notification to FDA of GRAS determinations. This paper analyzes GRAS notifications submitted during the Interim Pilot Program along with warning letters issued during the same time period to better understand the evolution of the program and anticipate the future GRAS landscape. The success of the GRAS Notification program is demonstrated by the increasing rate of GRAS Notifications submitted to the FDA during the Interim Pilot Program, as well as the shift from a primarily domestic process to a process featuring an equal to greater contribution of GRAS Notifications from companies outside the US. Analysis of the first 600 GRAS Notifications revealed a number of interesting trends regarding the inclusion and composition of GRAS Expert Panels; differences in notifications for substances with nutritive, processing aid, or effect; and the duration of GRAS Notifications. The review of FDA warning letters associated with GRAS issues provides additional insight into GRAS notices, from the perspective of ongoing post-market emphasis on food safety with the implementation of the GRAS Final Rule.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fct.2017.03.064 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The ECOST-CRT study assessed whether integrating a comprehensive remote monitoring (RM) scheme into heart failure (HF) care could improve patient outcomes compared to standard RM methods.
- 652 patients with cardiac resynchronization therapy (CRT) devices were split into two groups: one receiving only standard monitoring and the other receiving additional symptom tracking and notifications.
- Despite finding better quality of life improvements in the comprehensive RM group, the study did not show a significant difference in all-cause mortality or hospitalizations for worsening heart failure, partly due to early termination caused by the COVID-19 pandemic.
Retrospective analysis of carcinogenicity assessments within FDA-notified GRAS determinations.
Hum Exp Toxicol
July 2024
Abbott Nutrition, Columbus, OH, USA.
Frameworks have been developed to standardize the assessment of carcinogenic potential in the pharmaceutical and agrochemical industries, building upon decades of research. Carcinogenicity is also evaluated during the safety evaluation of food substances, using a comprehensive approach unique to each substance. To better understand these approaches, a retrospective assessment was conducted on the publicly available database of substances notified to the United States Food and Drug Administration (US FDA) as being Generally Recognized As Safe (GRAS).
View Article and Find Full Text PDFCurrent status of the novel food ingredient safety evaluation system.
Food Sci Biotechnol
January 2024
Department of Food and Nutrition, Dongduk Women's University, Seoul, 02748 Republic of Korea.
Increasing demand for new foods, technological development, and vegan market growth have led to an increase in new food ingredients, so the need for safety assessment of these ingredients is important. Representative safety assessment systems are the Generally Recognized as Safe (GRAS) notification of the Food and Drug Administration in the USA and the novel food system of the European Food Safety Authority in the European Union. GRAS is a notification system for information on food ingredients, food additives and functional foods under the responsibility of the applicant, while the novel food system assesses the safety of food ingredients excluding food additives.
View Article and Find Full Text PDFTrends in ingredients added to infant formula: FDA's experiences in the GRAS notification program.
Food Chem Toxicol
August 2023
Division of Food Ingredients, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, USA. Electronic address:
Article Synopsis
- Human milk is the best nutrition for infants for the first six to twelve months, but safe and adequate alternatives like infant formula are also essential for growth and development.
- In the U.S., the FDA ensures infant formula safety through stringent evaluations of ingredients and compliance with regulations under the Federal Food, Drug, and Cosmetic Act.
- Many formula ingredients are either previously proven safe for infants or closely resemble components found in human milk, and the GRAS Notification program helps manufacturers verify ingredient safety.
Extraction, nutrition, functionality and commercial applications of canola proteins as an underutilized plant protein source for human nutrition.
Adv Food Nutr Res
August 2022
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada. Electronic address:
Concerns about sustainability and nutrition security have encouraged the food sector to replace animal proteins in food formulations with underutilized plant protein sources and their co-products. In this scenario, canola protein-rich materials produced after oil extraction, including canola cold-pressed cakes and meals, offer an excellent opportunity, considering their nutritional advantages such as a well-balanced amino acid composition and their potential bioactivity. However, radical differences among major proteins (i.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!